Viloxazine Hydrochloride

CAS 35604-67-2 16 current recordsSmall Molecule

Who holds supplier records for Viloxazine Hydrochloride? 16 organisations hold a current record for Viloxazine Hydrochloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (12), Italy (1), Canada (1), United States (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Viloxazine Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/viloxazine-hydrochloride

Reading the evidence

  • 16 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    12 of the 16 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 12 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (16)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Viloxazine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Viloxazine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Viloxazine Hydrochloride is a selective norepinephrine reuptake inhibitor used primarily in the treatment of attention deficit hyperactivity disorder (ADHD). It works by modulating the levels of certain neurotransmitters in the brain to improve attention, focus, and impulsivity.

Chemical identity

IUPAC name
2-[(2-ethoxyphenoxy)methyl]morpholine;hydrochloride
Canonical SMILES
CCOC1=CC=CC=C1OCC2CNCCO2.Cl
InChIKey
HJOCKFVCMLCPTP-UHFFFAOYSA-N
Synonyms
Qelbree API, ici 58,834, ici-58834, qelbree, spn-812, spn812, viloxazine hcl, vivalan

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Norepinephrine Reuptake Inhibitor
Mechanism of action
Cytochrome P450 1A2 Inhibitors; Cytochrome P450 2B6 Inhibitors; Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A4 Inhibitors; Norepinephrine Uptake Inhibitors

Therapeutic areas

Attention Deficit Hyperactivity Disorder (ADHD)Norepinephrine Reuptake Inhibitor

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Viloxazine Hydrochloride?

16 organisations hold an active US FDA Type II Drug Master File or a CEP for Viloxazine Hydrochloride: Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), AMSA SPA (Italy), APITORIA PHARMA PRIVATE LTD (India), Apotex Inc. (Canada), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CREEKWOOD PHARMACEUTICALS LLC (United States) and CURIA SPAIN SAU (Spain), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Viloxazine Hydrochloride Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 40004), ALIVUS LIFE SCIENCES LTD (DMF 43933), AMSA SPA (DMF 39799), APITORIA PHARMA PRIVATE LTD (DMF 40673), Apotex Inc. (DMF 40648), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 39333), CREEKWOOD PHARMACEUTICALS LLC (DMF 40706) and CURIA SPAIN SAU (DMF 39826) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Viloxazine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Viloxazine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.